98%
921
2 minutes
20
Background: Tuberous sclerosis complex (TSC) is a multisystem genetic disorder often accompanied by neuropsychiatric symptoms, including epilepsy and cognitive impairments. While the cognitive impact of epilepsy in TSC is well documented in children, there is a paucity of studies examining neuropsychological functioning in high-functioning adults, particularly in relation to epilepsy status.
Objective: This study aimed to investigate cognitive functioning in adults with clinically or molecularly confirmed TSC, without intellectual disability or autism spectrum disorder (ASD), with a specific focus on the impact of epilepsy.
Methods: Fifty-six adults were divided into three groups: individuals with TSC and epilepsy (EpiTSC; n = 18), individuals with TSC without epilepsy (NEpiTSC; n = 19), and healthy controls (n = 37). Participants underwent a comprehensive neuropsychological assessment targeting executive functions, attention, memory, and visuospatial abilities. Statistical analyses included ANOVA, Tukey's post-hoc tests, and Mann-Whitney U tests, with additional analyses limited to participants with confirmed TSC2 pathogenic variants.
Results: Individuals with TSC and epilepsy exhibited significantly poorer performance on tasks assessing psychomotor speed, attention shifting, and executive control, including the Colour Trail Test and Trail Making Test. They also demonstrated lower scores in verbal memory and learning tasks, with a higher frequency of perseverative and intrusion errors on the California Verbal Learning Test (CVLT). Adults without epilepsy showed a distinct profile, characterized mainly by deficits in executive functioning and verbal fluency compared to controls. No significant group differences were observed in demographic variables.
Conclusions: This study highlights the existence of two distinct cognitive phenotypes among high-functioning adults with TSC, based on epilepsy status. Epilepsy in this cohort is associated with global cognitive dysfunction, particularly affecting attention, executive control, and memory. These findings underscore the need for individualized cognitive assessment and targeted intervention strategies, especially in individuals with a history of epilepsy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.seizure.2025.07.021 | DOI Listing |
Front Neuroanat
August 2025
Department of Biology, University of Graz, Graz, Austria.
Animals use different communication modalities for social interactions, often showing sensory adaptations linked to their preferred signaling system. How such adaptations affect individual processing centers usually remains elusive due to interspecies differences. One system in which such adaptations can be investigated are catfish.
View Article and Find Full Text PDFCNS Drugs
September 2025
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Objective: To characterize multinational trends and patterns of opioid analgesic prescribing by sex and age.
Design, Setting, And Participants: We studied opioid analgesic prescribing from 2001 to 2019 with common protocol using population-based databases from eighteen countries and one special administrative region.
Main Outcome Measures: We measured opioid prescribing by geographical region, sex and age, estimating annual prevalent, incident, and nonincident opioid prescribing per 100 population with a 95% confidence interval (CI) and meta-analyzed the multinational and regional opioid prescribing with a random-effects model.
Epilepsy Behav
October 2025
Department of Neurosurgery, National & Kapodistrian University of Athens, Greece.
Purpose: The burden of disease associated with tuberous sclerosis complex (TSC) places significant strain on both individuals with the condition and their families. Research has primarily focused on patients, with limited attention to caregiver experiences. This review aims to summarize current knowledge, identify key burden factors, and highlight the unmet needs of caregivers in TSC.
View Article and Find Full Text PDFOrphanet J Rare Dis
August 2025
Nobelpharma America, LLC. 3, 4520 East-West Highway, Suite 400, Bethesda, MD, 20814, USA.
Background: This analysis was aimed to characterize cutaneous manifestations associated with tuberous sclerosis complex (TSC) and management of facial angiofibroma in the United States from a patient/caregiver perspective. Data was collected from an international survey of TSC Alliance conducted during May-June 2017 by distributing a link to patients/caregivers through various channels including social media.
Results: Of the 418 caregivers and 133 patients, 336 (80.
Am J Intellect Dev Disabil
September 2025
Latha Valluripalli Soorya, Department of Psychiatry & Behavioral Sciences, Rush University Medical Center; Camille W. Brune, Department of Psychiatry & Behavioral Sciences, Rush University Medical Center; Cristan A. Farmer, Neurodevelopmental and Behavioral Phenotyping Service, National Institute of
The Developmental Synaptopathies Consortium is a multisite natural history network studying rare, neurogenetic syndromes associated with synaptic dysfunction and developmental delays. One aim of the Consortium is clinical trial readiness, including identifying clinical concepts and validating their measurement. We evaluated the scope and limitations of conventional cognitive and behavioral measurement strategies in 2-21-year-olds with Phelan-McDermid syndrome (PMS; N = 98), Tuberous Sclerosis Complex (TSC; N = 98), and PTEN Hamartoma Tumor syndrome (PHTS; N = 69).
View Article and Find Full Text PDF